Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 189
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01656304 | Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy | ||
| NCT00691015 | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant | ||
| NCT03406858 | Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT00301808 | Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer | ||
| NCT00872677 | Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors | ||
| NCT02145078 | Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer | ||
| NCT00011973 | Chemotherapy in Treating Patients With Advanced Kidney Cancer | ||
| NCT00244933 | Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer | ||
| NCT06537687 | Relational Agents in Cervical Cancer Education (RACE) | ||
| NCT00002656 | Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT00942422 | Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma | ||
| NCT05738005 | Dietary Reporting in the Amyloidoses | ||
| NCT00002547 | Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome | ||
| NCT01888198 | Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment | ||
| NCT02372877 | Evaluation of the AMICUS RBCx System in Sickle Cell Patients | ||
| NCT03328091 | Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) | ||
| NCT02178436 | Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer | ||
| NCT07227831 | A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer | ||
| NCT00248560 | Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer | ||
| NCT03719677 | Reducing Metabolic Syndrome Among Breast Cancer Survivors | ||
| NCT02824029 | Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma | ||
| NCT00258284 | Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer | ||
| NCT00768118 | A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants | ||
| NCT03453489 | AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm | ||
| NCT03183050 | MEND 2: Making Treatment Decisions Using Genomic Testing | ||
| NCT02178163 | Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer | ||
| NCT05903092 | MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer | ||
| NCT00003626 | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy | ||
| NCT00459121 | Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery | ||
| NCT06908629 | Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors | ||
| NCT06576115 | Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer | ||
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT00906503 | Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules | ||
| NCT02620865 | BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer | ||
| NCT07222306 | Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study | ||
| NCT01813370 | A Registry for Patients Treated on the Clinical Trial TAX 3503 | ||
| NCT06339827 | ASk Questions in GYnecologic Oncology (ASQ-GYO) | ||
| NCT00004022 | Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma | ||
| NCT01116232 | Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation | ||
| NCT00288028 | Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant | ||
| NCT00899665 | Proteases in Patients With Prostate Cancer That Has Spread to the Bone | ||
| NCT00244946 | Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma | ||
| NCT03091257 | A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma | ||
| NCT01420874 | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) | ||
| NCT00068653 | Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer | ||
| NCT00293384 | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant | ||
| NCT00514215 | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | ||
| NCT00305747 | Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy | ||
| NCT00521261 | Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | ||
| NCT02568449 | Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent |
